The Norwegian Adult Achondroplasia Study
NCT03780153 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2022-10-31
Summary
The study aims to investigate the Norwegian adult achondroplasia population regarding degree and extent of symptoms and clinical manifestations and how this population manages in daily life, including demographics, physical function, and work participation.
Conditions
Interventions
- OTHER
-
No intervention
Observation study. No intervention
Sponsors & Collaborators
-
Sunnaas Rehabilitation Hospital
lead OTHER
Principal Investigators
-
Vegard Strom, Phd · Sunnaas Rehabilitation Hospital
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-03-01
- Primary Completion
- 2019-03-31
- Completion
- 2022-03-21
Countries
- Norway
Study Locations
More Related Trials
-
Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)
NCT04035811 ·Status: COMPLETED
-
Lifetime Impact of Achondroplasia Study in Europe-LIAISE
NCT03449368 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia
NCT05353192 ·Status: UNKNOWN ·Phase: PHASE4
-
Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin
NCT00488124 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Somatropin in Turner Syndrome
NCT01518036 ·Status: COMPLETED ·Phase: PHASE3
-
A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin
NCT01435629 ·Status: COMPLETED
-
Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy)
NCT05328050 ·Status: RECRUITING
-
French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome
NCT05308927 ·Status: ENROLLING_BY_INVITATION
-
A Multicenter, Multinational Clinical Assessment Study for Pediatric Patients With Achondroplasia
NCT01603095 ·Status: COMPLETED
-
French National Registry of Children Born Small for Gestational Age Treated With Somatropin
NCT01578135 ·Status: COMPLETED
-
Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome
NCT01529840 ·Status: COMPLETED ·Phase: PHASE3
-
Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome
NCT01927861 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients
NCT01562834 ·Status: COMPLETED ·Phase: PHASE4
-
Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome
NCT00705172 ·Status: COMPLETED
-
A Phase 2 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia
NCT06433557 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature
NCT01778023 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study of Growth Hormon to Treat SMA Typ II and III
NCT00533221 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
NCT05894876 ·Status: TERMINATED
-
Eisenmenger Syndrome in the Nordic Countries
NCT01976533 ·Status: UNKNOWN
-
Follow-up to Adult Height of a Cohort of Subjects Born Small for the Gestational Age and Treated With Growth Hormone
NCT01196156 ·Status: COMPLETED
-
Study of Skeletal Disorders and Short Stature
NCT00001754 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation
NCT03535415 ·Status: UNKNOWN ·Phase: PHASE3
-
Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age
NCT00174460 ·Status: COMPLETED ·Phase: PHASE2
-
Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopathic Short Stature
NCT00355030 ·Status: COMPLETED ·Phase: PHASE3
-
Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone Deficiency
NCT01698944 ·Status: TERMINATED ·Phase: PHASE4